Showing results (171-180 of 201) with videos related to

Sort By:
Pageof 21
Cancer|January 16, 2025
Olaparib as treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysisYing L Liu, Cara A Mathews, Fiona Simpkins, et al.
Gynecologic Oncology|July 16, 2023
Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary studyTiffany Y Sia, Beryl L Manning-Geist, Sarah Ehmann, et al.
The American Journal of Gastroenterology|February 27, 2025
Neoplasia Detection Through Colonic Surveillance Among Young Individuals With MSH6 / PMS2 -Associated Lynch SyndromeAlicia Latham, Ying L Liu, Gillain Constantino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2022
MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian CarcinomaBeryl Manning-Geist, Sushmita Gordhandas, Ying L Liu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 22, 2026
Prognostic comparison of the FIGO 2009 and 2023 endometrial cancer staging systems: a large, single-institution retrospective cohort studyTiffany Y Sia, Qin Zhou, Sean Devlin, et al.
Cancer Discovery|August 31, 2023
Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic ImplicationsBritta Weigelt, Antonio Marra, Pier Selenica, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 29, 2022
Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndromeYing L Liu, Karen A Cadoo, Anna Maio, et al.
JCO Precision Oncology|December 23, 2024
Optimizing Mainstreaming of Genetic Testing in Parallel With Ovarian and Endometrial Cancer Tumor Testing: How Do We Maximize Our Impact?Ying L Liu, Tiffany Y Sia, Nancy Varice, et al.
Patient Education and Counseling|February 5, 2026
Adapting mainstreaming genetic education and clinical communication materials for cancer patients of varying backgroundsStephanie N Christian-Afflu, Rania Sheikh, Anna Strang, et al.
Gynecologic Oncology|January 20, 2023
Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide managementYing L Liu, Beryl L Manning-Geist, Andrea Knezevic, et al.
Pageof 21